ENBI Share Price Performance
CA$0.07
-0.09 (-56.25%)
Price CA$0.07
Share PriceCA$0.07
Entheon Biomedical Corp. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ENBI Community Narratives
There are no narratives available yet.
Recent ENBI News & Updates
Entheon Biomedical Corp. Key Details
Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.025
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Entheon Biomedical Corp. Competitors
Snowflake Analysis
About ENBI
- Founded
- n/a
- Employees
- 1
- CEO
- WebsiteView website
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Canadian Market Performance
- 7 Days: 1.1%
- 3 Months: 10.3%
- 1 Year: 22.1%
- Year to Date: 20.3%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 5.0% in that time. As for the longer term, the market has risen 23% in the past 12 months. Looking forward, earnings are forecast to grow by 11% annually. Market details ›